Hong Ren
Qingdao University(CN)Jiangnan University(CN)Guangzhou University of Chinese Medicine(CN)University of British Columbia(CA)Guizhou University(CN)Shanghai Jiao Tong University(CN)Dalian Medical University(CN)Sichuan University(CN)Ruijin Hospital(CN)Vancouver General Hospital(CA)Chinese PLA General Hospital(CN)Shanghai Children's Medical Center(CN)Second Affiliated Hospital of Chongqing Medical University(CN)Fifth Tianjin Central Hospital(CN)Aba Teachers University(CN)Qingdao Municipal Hospital(CN)First Affiliated Hospital of Xi'an Jiaotong University(CN)Changchun University of Chinese Medicine(CN)Shanxi Fenyang Hospital(CN)Institute of Natural Science(KP)Children's Hospital of Fudan University(CN)Shanghai Municipal Center For Disease Control Prevention(CN)Chongqing Medical University(CN)
Publications by Year
Research Areas
Hepatitis B Virus Studies, Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Renal Diseases and Glomerulopathies, Hepatitis Viruses Studies and Epidemiology
Most-Cited Works
- → Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study(2023)612 cited
- → Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials(2021)451 cited
- → Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound(2016)439 cited
- → CSH guidelines for the diagnosis and treatment of drug-induced liver injury(2017)293 cited
- → Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update)(2017)275 cited
- → Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials